Preparing for China · patient guide

Preparing for myelodysplastic syndrome care in China

Start by clarifying what you want the Chinese haematology team to decide: a records-based opinion, confirmation of your MDS subtype and risk group, or a treatment plan you could follow in China. Send a concise summary first, then the blood counts, bone marrow report, cytogenetics, molecular results and current treatment list. No overseas team can promise acceptance or a particular therapy before reviewing your case.

Go to the practical guidance ↓
AI illustration: A doctor discusses documents with a patient in a consultation room.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Define the question before you collect the file

Myelodysplastic syndrome is not one condition. The 2022 International Consensus Classification and the fifth edition of the WHO classification both separate MDS subtypes using blood counts, marrow morphology, blast percentage and genetic findings, and the IPSS-M score combines clinical and molecular variables to estimate risk. That means a Chinese haematologist cannot give you a useful opinion from a diagnosis line alone. The first planning task is to decide which question you need answered.

Common questions differ in what records they need. You may want to know whether the marrow findings have been interpreted consistently, whether your current risk category is agreed, what treatment options a Chinese centre would consider, or whether a specific approach such as hypomethylating therapy, immunosuppressive treatment or allogeneic transplant assessment is relevant to your subtype. Each of these requires the treating team's own review; an enquiry service can organise the question but cannot answer it.

Write your question in two or three sentences. For example: "I was diagnosed with MDS with excess blasts in 2024 and have been on azacitidine. I want a records-based opinion on whether my risk group and treatment plan are appropriate, and whether transplant assessment should be discussed." A focused question helps the receiving team decide which records matter and prevents a long archive from obscuring the key issue.

The records a haematology team will want to see

Ask your current haematologist or hospital records department for copies rather than summaries where possible. The most useful set usually includes full blood count trends with dates, the bone marrow aspirate and trephine biopsy reports, flow cytometry if performed, karyotype and FISH results, and any molecular panel covering genes such as SF3B1, TP53, ASXL1, RUNX1 and splicing factors. The IPSS-M requires many of these variables, so missing molecular results can limit a risk assessment.

Also include the treatment history: drugs, doses, start and stop dates, transfusion requirements and responses, iron chelation if used, growth factors, and any infections or admissions. A list of current medicines with doses, allergies and other conditions matters because MDS care often involves older patients with cardiac, renal or other comorbidity. If a transplant has been discussed, note whether a donor search or HLA typing has begun.

You do not need to send everything at once. A short summary with the key reports lets the team see whether your question can be addressed. Ask how records should be shared, in what format and whether translation is needed. Pathology slides and blocks may be requested for review; confirm the laboratory's requirements for releasing material before shipping anything.

  • Full blood counts with dates, not a single value
  • Bone marrow aspirate and biopsy reports
  • Karyotype, FISH and molecular panel results
  • Treatment history with doses and responses
  • Transfusion and iron chelation history
  • Current medicines, allergies and other conditions

What a records-based opinion can and cannot settle

A records-based haematology opinion can review whether the diagnosis and risk classification are supported, discuss guideline-concordant options and identify questions your local team may need to address. It cannot examine you, repeat the marrow, confirm fitness for a particular procedure or guarantee that a Chinese hospital will accept you for treatment. Those decisions belong to the treating hospital after its own assessment.

This distinction matters for planning. A remote opinion may support your decision about whether travelling is worthwhile, but it does not establish eligibility for a clinical trial, transplant access or availability of a named medicine. If your question concerns an investigational approach, ask separately what the hospital's process is and what confirmation would be required. Do not treat a positive preliminary reply as an offer of treatment.

ChinaSpecialistCare's free initial case review checks the available diagnosis, records and your main question, identifies missing information and suggests a next step. It is not a diagnosis and not a promise of acceptance. A proxy consultation, where a doctor takes records to a hospital specialist while you remain at home, is optional and not a prerequisite for every appointment.

Related treatment reference

Questions to ask about treatment and transplant assessment

Prepare a short list of clinical questions rather than asking for a general opinion. Useful questions include: which MDS subtype and risk category does the team assign, and on what evidence; which treatment options would it consider and why; what would make a difference to the plan; whether transplant assessment is relevant given age, comorbidity and donor status; and what monitoring or supportive care the plan would involve. Ask the team to explain the uncertainty in its answers.

Transplant deserves separate handling. Allogeneic transplant is a potential treatment for some patients with higher-risk MDS, but suitability depends on disease status, age, performance status, organ function, donor availability and the centre's own assessment. A records review can raise the question; it cannot confirm access. Ask explicitly what the hospital requires before it can discuss transplant, and what information it needs from a donor registry or family typing.

For medicines, ask what the hospital can prescribe and monitor, and what documentation it needs about prior treatment. Do not assume that a drug available in your home country is available, funded or appropriate in China. These are questions for the treating team and hospital, not for a coordination service.

Practical preparation for a possible visit

If a visit becomes relevant, plan around the clinical question rather than a fixed itinerary. Ask the hospital how many visits an assessment might involve, what tests would be repeated and whether results would be available during your stay; these are questions to confirm with the named provider, not assumptions about Chinese hospitals. Ask whether an interpreter is needed for consultations and consent discussions, and who would provide it.

Bring original reports and a translated summary if your records are not in English or Chinese. Keep a current medication list and a contact for your home haematologist, because the Chinese team may want to discuss prior treatment. Arrange insurance and payment questions directly with the hospital; hospital fees and any coordination fees are separate, and ChinaSpecialistCare does not collect or refund hospital payments.

For travel logistics, airport pickup, visa-document assistance and hotel arrangements can be discussed, but no visa outcome or appointment date should be assumed. Ask for the current scope and price of any arrival support before committing, and confirm what a quoted pickup covers. Hospital companion and interpretation support is a separately agreed non-clinical service, so ask what hours, tasks and languages it includes rather than assuming it covers clinical discussions.

A realistic next step

Begin with a brief summary through the enquiry form, email or WhatsApp: your diagnosis and date, current treatment, the question you want answered and the key reports you hold. Do not send passport numbers, card details or a complete medical archive at first contact. The team can then explain what is missing and whether a records-based opinion or a specialist appointment is the sensible route.

Keep your local haematology care in place while you explore options. If your blood counts are falling quickly, you have a fever or infection, or you feel acutely unwell, seek local urgent assessment rather than waiting on an overseas enquiry. An initial enquiry is free, and no proxy consultation is required to ask whether your question can be addressed.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Related treatment reference
  2. Myelodysplastic Syndromes Treatment - NCI

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.